latrogenic hyperadrenocorticism and secondary hypoadrenocorticism in c
ats has only been documented in the past as a sequel to experimental g
lucocorticoid administration. To the authors' knowledge, this is the f
irst report in the literature of iatrogenic hyperadrenocorticism and c
omplicating factors in the clinical setting. A cat was treated with de
xamethasone for 2.5 years for cervical discomfort caused by an unsuspe
cted vertebral osteoma at C-7. The cat developed progressive tetrapare
sis, and muscle wasting attributed to superimposed glucocorticoid-indu
ced myopathy as determined by electromyographic, serum chemistry, and
histopathologic testing. Other manifestations of hyperadrenocorticism
were bilaterally symmetrical alopecia, thin skin, cutaneous bruising,
and bilaterally symmetrical cataracts along the suture lines of the le
ns. The cat had adrenal hyporesponsiveness as measured by reduced adre
nal cortisol secretion in response to exogenous adrenocorticotropic ho
rmone (ACTH). Feline infectious peritonitis was suspected to be a comp
licating illness on the basis of histopathologic findings.